NASDAQ:CYTK
Cytokinetics Stock News
$65.34
+0.540 (+0.83%)
At Close: Apr 26, 2024
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Novavax (NVAX)
11:09am, Friday, 24'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cytokinetics (CYTK) and Novavax (NVAX) with bullish
Analysts Offer Insights on Healthcare Companies: Cytokinetics (NASDAQ: CYTK) and Novavax (NASDAQ: NVAX)
11:09am, Friday, 24'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cytokinetics (
CYTK
–
Research Report
) and Novavax (
NVAX
–
Research Report
) with bullish sentime
Cytokinetics Inc:
Assenagon Asset Management S.A. Acquires Shares of 121,510 Cytokinetics, Inc. (NASDAQ:CYTK)
09:22am, Thursday, 23'rd Apr 2020
Assenagon Asset Management S.A. acquired a new stake in Cytokinetics, Inc. (NASDAQ:CYTK) during the first quarter, according to its most recent filing with the SEC. The firm acquired 121,510 shares of
Cytokinetics to Announce First Quarter Results on May 6, 2020
08:00pm, Wednesday, 22'nd Apr 2020
Cytokinetics, Incorporated (CYTK) today announced that it is scheduled to report first quarter results on May 6, 2020 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics’ senior manag
Cytokinetics to Announce First Quarter Results on May 6, 2020
08:00pm, Wednesday, 22'nd Apr 2020
SOUTH SAN FRANCISCO, Calif., April 22, 2020 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report...
Agile Therapeutics nominates Sharon Barbari to board of directors AGRX;CYTK;GILD
12:47pm, Wednesday, 22'nd Apr 2020
Agile Therapeutics nominates Sharon Barbari to board of directors AGRX CYTK GILD
Agile Therapeutics Announces Changes to its Board of Directors
12:00pm, Wednesday, 22'nd Apr 2020
Agile Therapeutics, Inc. (AGRX), a forward-thinking women’s healthcare company, today announced that the company has nominated Sharon Barbari for election as a class III director to replace Abhijeet
Cytokinetics to Announce First Quarter Results on May 6, —…—…
12:00am, Wednesday, 22'nd Apr 2020First Citizens Bank & Trust Co. Grows Stock Position in Cytokinetics, Inc. (NASDAQ:CYTK)
10:34am, Tuesday, 21'st Apr 2020
First Citizens Bank & Trust Co. lifted its stake in Cytokinetics, Inc. (NASDAQ:CYTK) by 24.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exc
Cytokinetics (NASDAQ:CYTK) Price Target Increased to $23.00 by Analysts at Cantor Fitzgerald
09:48am, Tuesday, 21'st Apr 2020
Cytokinetics (NASDAQ:CYTK) had its price objective boosted by Cantor Fitzgerald from $12.00 to $23.00 in a research report report published on Friday, Benzinga reports. Cantor Fitzgerald currently has
Morgan Stanley Upgrades Cytokinetics (NASDAQ:CYTK) to Overweight
06:04am, Tuesday, 21'st Apr 2020
Cytokinetics (NASDAQ:CYTK) was upgraded by equities research analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a report issued on Sunday, Benzinga reports.
Cubist Systematic Strategies LLC Sells 13,419 Shares of Cytokinetics, Inc. (NASDAQ:CYTK)
09:18am, Monday, 20'th Apr 2020
Cubist Systematic Strategies LLC reduced its stake in Cytokinetics, Inc. (NASDAQ:CYTK) by 81.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Comm
Cytokinetics, Inc. (NASDAQ:CYTK) Stake Increased by Alliancebernstein L.P.
08:30am, Sunday, 19'th Apr 2020
Alliancebernstein L.P. increased its holdings in shares of Cytokinetics, Inc. (NASDAQ:CYTK) by 3.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exch
